TCS, HDFCBANK, SBI Liquid Fund (G)
Glenmark Pharmaceuticals Ltd.
Glenmark Pharma
NSE
₹ 0.00
0.00 (0.00)%
Healthcare
Mid-cap
With a market cap of ₹18.90L Cr.
Moderate Volatility
Stock is 1.13x as volatile as index
Financial Strength
Stable
Ratios Analysis
Balance Sheet
Results Analysis
Cash Flow
Profit Loss
Key Metrics
Market Capitalisation
₹ 38959.23 Cr.
Enterprise Value
₹ 38303 Cr.
Shares Outstanding
28.22 Cr.
Dividend Yield
0.18%
Face Value
₹ 1
Book Value
₹ 863.21
TTM EPS
215.32 Cr.
TTM-PE
6.41
Latest Equity
28.22
Latest Reserve
₹ 24332
Peers Comparison
| Stocks | CMP (₹) | Mark. Cap Size | P/E | P/B | EPS | ROE |
|---|---|---|---|---|---|---|
| Ipca Laboratories | Loading... | Mid-cap | 57.39 | 4.96 | 21.57 | 8.7 |
| Ajanta Pharma | Loading... | Mid-cap | 25.89 | 4.49 | 46.7 | 17.68 |
| Wockhardt | Loading... | Small-cap | 0 | 0.66 | -38.82 | -17.32 |
| Astrazeneca Pharma I | Loading... | Small-cap | 81.76 | 13.85 | 39.72 | 18.13 |
